Back
Alkermes PLC Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
48
ALKS
Alkermes PLC
Last Price:
$33.89
Seasonality Move:
2.42%
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
Sell
48
Alkermes PLC (ALKS)
is a Sell
Is Alkermes PLC a Buy, Sell or Hold?
-
The current Alkermes PLC [ALKS] share price is $34.79. The Score for ALKS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ALKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $34.79The current trend is moderately bearish and ALKS is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $290.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
ALKS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 56.59 | Buy |
Chaikin Money Flow: | -1005526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.99 - 35.45) | Buy |
Bollinger Bands (100): | (28.1 - 33.5) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.72 | Buy |
Relative Strength Index (14 RSI): | 71.41 | Buy |
Chaikin Money Flow: | -979016 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.44 - 263) | Buy |
Bollinger Bands (100): | (240.32 - 271.8) | Buy |
ALKS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.25 | Buy |
20-day SMA: | 34.44 | Buy |
50-day SMA: | 32.65 | Buy |
200-day SMA: | 28.62 | Buy |
8-day EMA: | 34.39 | Buy |
20-day EMA: | 34.19 | Buy |
50-day EMA: | 32.99 | Buy |
200-day EMA: | 29.75 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 257.74 | Buy |
20-day SMA: | 249.75 | Buy |
50-day SMA: | 257.54 | Buy |
200-day SMA: | 251.5 | Buy |
8-day EMA: | 263.89 | Buy |
20-day EMA: | 256.08 | Buy |
50-day EMA: | 255.39 | Buy |
200-day EMA: | 243.44 | Buy |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.02 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Alkermes PLC Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |